A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
- for people ages 18 years and up (full criteria)
- at UCSD
- study startedestimated completion
Gastroparesis Diabetes Mellitus diabetic gastroparesis vomiting Relamorelin Relamorelin 10 μg
- accepting new patients
- Start Date
- Completion Date
- Additional information on study locations near you may be found at AllerganClinicalTrials.com. For any study not on AllerganClinicalTrials.com, please contact IR‐CTRegistration@Allergan.com for assistance.
- To be considered as a site for current and future Allergan Clinical Trials, please register using the Investigator Databank link.
- Phase 3
- Study Type
- Last Updated